Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable recep...
Leadership
Frank M. Torti M.B.A., M.D.
Executive Chairperson of the Board
Eric Venker M.D., Pharm.D.
CEO & Director
Melanie Gloria B.S.N.
Chief Operating Officer
Christopher A. Van Tuyl Esq., J.D.
Chief Legal Officer & Corporate Secretary
Tiago M. Girao CPA
Chief Financial Officer
Jay S. Stout M.S., Ph.D.
Chief Technology Officer
Christine Blodgett
Senior Vice President of Human Resources
Andy Deig M.B.A.
Senior Vice President of Strategic Finance
Julie Kirschling
Senior Vice President of Program & Alliance Management
